title: Darexaban has high sensitivity in the prothrombin time clotting test.
authors.forename: T
authors.initials: T
authors.lastname: Funatsu
authors.forename: Y
authors.initials: Y
authors.lastname: Iwatsuki
authors.forename: S
authors.initials: S
authors.lastname: Kaku
mesh_terms: D001381:Azepines / Q000494:pharmacology*; D001549:Benzamides / Q000494:pharmacology*; D001777:Blood Coagulation / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D020719:Glucuronides / Q000494:pharmacology; D006801:Humans; D009025:Morpholines / Q000494:pharmacology; D011237:Predictive Value of Tests; D011517:Prothrombin Time; D011720:Pyrazoles / Q000494:pharmacology; D011728:Pyridones / Q000494:pharmacology; D000069552:Rivaroxaban; D012680:Sensitivity and Specificity; D013876:Thiophenes / Q000494:pharmacology
chemical_list: D001381:Azepines; D001549:Benzamides; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents; D020719:Glucuronides; D009025:Morpholines; D011720:Pyrazoles; D011728:Pyridones; D013876:Thiophenes; C570990:darexaban glucuronide; C522181:apixaban; D000069552:Rivaroxaban; C569750:darexaban